Virtus LifeSci Biotech Products ETF(BBP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BBP Virtus LifeSci Biotech Products ETF

盘前交易 07-24 05:49:12 EDT

97.26

+0.30

+0.31%

最高97.47	最低95.60	成交量7,951
今开95.60	昨收96.96	日振幅1.93%
总市值9,726万	流通市值9,726万	总股本100.00万
成交额77.00万	换手率0.80%	流通股本100.00万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BBP","market":"US","secType":"STK","nameCN":"Virtus LifeSci Biotech Products ETF","latestPrice":97.262,"timestamp":1784836800000,"preClose":96.9597,"halted":0,"volume":7951,"delay":0,"changeRate":0.0031177901746808462,"floatShares":1000004,"shares":1000004,"eps":0,"marketStatus":"盘前交易","change":0.3023,"latestTime":"07-24 05:49:12 EDT","open":95.6,"high":97.47,"low":95.6,"amount":770033.955685,"amplitude":0.019286,"askPrice":154.64,"askSize":100,"bidPrice":39.1,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1784899800000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":97.262,"sharesOutstanding":600004,"nav":96.821,"aum":96821305.32,"bidAskSpread":0.002358,"postHourTrading":{"tag":"盘后","latestPrice":97.26,"preClose":97.262,"latestTime":"19:34 EDT","volume":15,"amount":1460.116,"timestamp":1784849644323,"change":-0.002,"changeRate":-0.000021,"amplitude":0},"volumeRatio":0.800656554083369,"impliedVol":0.2516,"impliedVolPercentile":0.76},"requestUrl":"/m/hq/s/BBP","defaultTab":"news","newsList":[{"id":"2653752990","title":"安永：至2028年全球前25大医药企业存在千亿美元增长缺口","url":"https://stock-news.laohu8.com/highlight/detail?id=2653752990","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653752990?lang=zh_cn&edition=full","pubTime":"2026-07-22 19:23","pubTimestamp":1784719424,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["MRNX","MRNY","BBP","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653584157","title":"创新药研发加速遇“猴荒”","url":"https://stock-news.laohu8.com/highlight/detail?id=2653584157","media":"三里河","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653584157?lang=zh_cn&edition=full","pubTime":"2026-07-22 16:21","pubTimestamp":1784708497,"startTime":"0","endTime":"0","summary":"“要站在‘猴’里，不要像猴子一样站在那里。”资本市场从来不缺故事。近期，昭衍新药业绩暴增，原因是实验猴市场价格上涨，带动公司手里的“猴子资产”大幅增值，多家相关概念公司股价也跟风大涨。甚至有人顺藤摸瓜，挖出了“香蕉概念”。网友戏称：这是产业链挖掘最深的一次。一只猴子，为什么能扰动资本市场？答案藏在药物的研发链条里。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607223817277458.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["SBIO","IBB","LFSC","PBE","XLVI","BK4588","WRND","GSKH","GDOC","BBP","APXH","BK4585","BIOY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651774435","title":"免疫疾病生物制药公司Attovia(ATTO.US)申请在美上市 拟募资1亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2651774435","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651774435?lang=zh_cn&edition=full","pubTime":"2026-07-15 11:17","pubTimestamp":1784085422,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，临床阶段生物制药公司Attovia Therapeutics已提交首次公开募股申请，计划募集最多1亿美元资金。该公司计划在纳斯达克上市，股票代码为“ATTO”。　　据悉，Attovia利用其ATTOBODY平台开发用于治疗免疫介导性疾病的生物制剂。Alamar于2023年设立Attovia作为独立公司，以便自身专注于蛋白质组学和疾病检测业务，目前仍是Attovia的重要股东。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260715/32307966.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["IPOS","MRNY","IBBQ","MRNX","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651435511","title":"免疫疾病生物制药公司Attovia(ATTO.US)申请在美上市 拟募资1亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2651435511","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651435511?lang=zh_cn&edition=full","pubTime":"2026-07-15 10:45","pubTimestamp":1784083531,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，临床阶段生物制药公司Attovia Therapeutics已提交首次公开募股申请，计划募集最多1亿美元资金。据悉，Attovia利用其ATTOBODY平台开发用于治疗免疫介导性疾病的生物制剂。自通过IPO融资2.2亿美元以来，Alamar股价已上涨近60%。Alamar于2023年设立Attovia作为独立公司，以便自身专注于蛋白质组学和疾病检测业务，目前仍是Attovia的重要股东。Attovia的核心候选药物ATTO-1310针对白细胞介素-31，目前已完成针对健康志愿者以及患有慢性瘙痒症和特应性皮炎患者的Ⅰ期临床试验给药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1467668.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IPOS","BBP","MRNY","MRNX","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651435505","title":"免疫疾病生物制药公司Attovia(ATTO.US)申请在美上市 拟募资1亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2651435505","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651435505?lang=zh_cn&edition=full","pubTime":"2026-07-15 10:45","pubTimestamp":1784083531,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IPOS","BBP","MRNY","MRNX","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651162210","title":"英硅智能早盘涨超7% 与康哲药业达成AI+创新药研发新合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2651162210","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651162210?lang=zh_cn&edition=full","pubTime":"2026-07-13 10:02","pubTimestamp":1783908120,"startTime":"0","endTime":"0","summary":"　　英硅智能早盘涨超7%，截至发稿，股价上涨6.21%，报45.48港元，成交额3.32亿港元。　　7月13日，据英硅智能官微消息，公司宣布与康哲药业在中枢神经系统领域开展另一项AI驱动的药物发现合作。　　根据合作协议，双方将结合英硅智能已验证的AI平台与AI赋能创新药研发能力，以及康哲药业经验丰富的研发团队和对疾病领域的深度认知，双方共同推进该研发项目的合作开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-07-13/doc-inihrnpk9058117.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["CHAT","IE00BYV24P56.USD","AIPO","SG9999015978.USD","LU2488822045.USD","PBE","AGIX","ARTY","IE00BVYPNP33.GBP","SG9999004220.SGD","SG9999015986.USD","BK4585","IE00BGHQDM52.EUR","SG9999015945.SGD","GSKH","VTHR","IBB","QTOC","IE00BMCWC346.EUR","SBIO","LFSC","BK1593","00867","BK4588","SG9999015952.SGD","BBP","IE00BVYPNQ40.USD","WRND","BK1191","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649952006","title":"（活力中国调研行）上海生物医药产业规模破万亿 张江药谷青年人才成创新药研发主力","url":"https://stock-news.laohu8.com/highlight/detail?id=2649952006","media":"中国新闻网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649952006?lang=zh_cn&edition=full","pubTime":"2026-07-08 11:56","pubTimestamp":1783482969,"startTime":"0","endTime":"0","summary":"中新网上海7月8日电(杨海燕马佳佳)“我们对青年人才‘如饥似渴’，上海团队有180多名全职员工，90%以上都是40岁以下的青年人才。”英硅智能全球对外合作负责人、副总裁王珏7日在“活力中国调研行”主题采访活动中介绍道。在上海张江药谷，这片曾经的农田已崛起为世界级生物医药创新高地，而活跃其中的青年人才，正成为推动创新药研发的主力军。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607083798154946.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607083798154946.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["WRND","BK4585","LFSC","PBE","BK4581","161726","GDOC","GSKH","BBP","XBI","IBB","SBIO","BK4588","399441"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649984355","title":"翰思艾泰-B(03378)：拟与华科前沿交叉研究中心打造新一代AI驱动的创新药研发范式","url":"https://stock-news.laohu8.com/highlight/detail?id=2649984355","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649984355?lang=zh_cn&edition=full","pubTime":"2026-07-07 18:57","pubTimestamp":1783421872,"startTime":"0","endTime":"0","summary":"智通财经APP讯，翰思艾泰-B 发布公告，为充分发挥产学研结合的优势，加速生物医药研发创新，公司于近日与华科—澳城大高等研究院前沿交叉研究中心正式签署了《“人工智能药物研发联合实验室”合作共建协议》。双方将依托华科前沿交叉研究中心的AI平台，以及翰思艾泰在创新药研发的丰富经验和对疾病领域的深度认知，围绕抗体发现与分子设计展开深度合作，共同打造新一代AI驱动的创新药研发范式。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1464249.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IBB","BK4588","BK4585","GDOC","BK1173","BBP","BK1535","ARTY","LFSC","03378","CHAT","VTHR","BK1161","PBE","SBIO","QTOC","AGIX","GSKH","WRND","AIPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649679149","title":"生物制药公司Crinetics盘后涨超100%福泰制药将以85美元/股收购公司。","url":"https://stock-news.laohu8.com/highlight/detail?id=2649679149","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649679149?lang=zh_cn&edition=full","pubTime":"2026-07-07 04:09","pubTimestamp":1783368555,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["VRTX","LU1674673691.USD","LU0320765992.SGD","IE0002141913.USD","LU2462157665.USD","IDNA","IE00BJJMRZ35.SGD","BBP","LU1778281490.HKD","IE00B19Z9P08.USD","LU0061475181.USD","SG9999013999.USD","BK4588","LU1035775433.USD","BBH","LU1674673428.USD","LU2237438978.USD","IBBQ","BK4567","IE00B19Z3581.USD","BK4533","BK4139","LU2362541273.HKD","IE00B2B36J28.USD","LU1585245621.USD","LU0289739699.SGD","IBB","PBE","BIB","IE00BJT1NW94.SGD","LU2362541513.USD","LU1093756325.SGD","LU0079474960.USD","LU2456880835.USD","LU2362540622.SGD","LU0823416689.USD","LU1093756168.USD","LU2324357040.USD","SG9999001176.USD","MRNY","MRNX","UUP","IE00B19Z9Z06.USD","SGXZ57979304.SGD","UDN","LU2236285917.USD","IE00BFTCPJ56.SGD","BK4585","LU2417539215.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625984433","title":"河北省市监局：13类产品抽检74批次不合格，涉贵金属饰品、成品油等","url":"https://stock-news.laohu8.com/highlight/detail?id=2625984433","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625984433?lang=zh_cn&edition=full","pubTime":"2026-04-07 13:22","pubTimestamp":1775539336,"startTime":"0","endTime":"0","summary":"针对问题产品，监管部门已责成属地市场监管部门依法处理。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1775538842223186739","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["SBS","BK4588","BK4585","BK4172","BBP","DEHP","BV","BK4220","BK4103","BK4120","IE00B1B80R65.USD","DBP"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0035},{"period":"1month","weight":0.0488},{"period":"3month","weight":0.1564},{"period":"6month","weight":0.1675},{"period":"1year","weight":0.5198},{"period":"ytd","weight":0.2171}],"compareEarnings":[{"period":"1week","weight":-0.0167},{"period":"1month","weight":0.0063},{"period":"3month","weight":0.034},{"period":"6month","weight":0.071},{"period":"1year","weight":0.1639},{"period":"ytd","weight":0.0825}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.013251},{"month":2,"riseRate":0.416667,"avgChangeRate":0.009089},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.010237},{"month":4,"riseRate":0.583333,"avgChangeRate":0.00248},{"month":5,"riseRate":0.583333,"avgChangeRate":0.009273},{"month":6,"riseRate":0.916667,"avgChangeRate":0.050034},{"month":7,"riseRate":0.75,"avgChangeRate":0.020565},{"month":8,"riseRate":0.636364,"avgChangeRate":0.016835},{"month":9,"riseRate":0.363636,"avgChangeRate":-0.015494},{"month":10,"riseRate":0.636364,"avgChangeRate":-0.014134},{"month":11,"riseRate":0.909091,"avgChangeRate":0.065286},{"month":12,"riseRate":0.363636,"avgChangeRate":-0.005253}],"exchange":"ARCA","name":"Virtus LifeSci Biotech Products ETF","nameEN":"Virtus LifeSci Biotech Products ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Virtus LifeSci Biotech Products ETF(BBP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Virtus LifeSci Biotech Products ETF(BBP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Virtus LifeSci Biotech Products ETF,BBP,Virtus LifeSci Biotech Products ETF股票,Virtus LifeSci Biotech Products ETF股票老虎,Virtus LifeSci Biotech Products ETF股票老虎国际,Virtus LifeSci Biotech Products ETF行情,Virtus LifeSci Biotech Products ETF股票行情,Virtus LifeSci Biotech Products ETF股价,Virtus LifeSci Biotech Products ETF股市,Virtus LifeSci Biotech Products ETF股票价格,Virtus LifeSci Biotech Products ETF股票交易,Virtus LifeSci Biotech Products ETF股票购买,Virtus LifeSci Biotech Products ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Virtus LifeSci Biotech Products ETF(BBP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Virtus LifeSci Biotech Products ETF(BBP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}